Rahoto kan sakamakon kudi na kamfanin Oncolys BioPharma Inc., Oncolys BioPharma Inc. shekara-shekara na samun kudin shiga ga shekara ta 2024. Yaushe Oncolys BioPharma Inc. buga rahotanni na kudi?
Oncolys BioPharma Inc. jimlar kudaden shiga, ribar shiga gida da kuma sauye-sauye na canje-canje a Yuro a yau
Net kudaden shiga na Oncolys BioPharma Inc. a kunne 30/06/2021 sun kasance masu yawa 130 464 000 €. Tasirin kudaden shiga na Oncolys BioPharma Inc. ya tashi. Canjin ya koma 67 861 000 €. Ana nuna ƙarfin kuɗin shiga yanar gizo idan aka kwatanta da rahoton da ya gabata. Waɗannan su ne manyan alamu na Oncolys BioPharma Inc.. Shafin kuɗi na Oncolys BioPharma Inc. yana nuna ƙimar da canje-canje na waɗannan alamomi: jimlar kadarori, kuɗin shiga yanar gizo, kudaden shiga. Jadawalin rahoton hada-hadar kudi daga 31/03/2019 zuwa 30/06/2021 yana kan layi. Oncolys BioPharma Inc. jimlar kudaden shiga akan zane an nuna shi da rawaya.
Rahoton Rahoton
Jimlar kudade
An kiyasta yawan kudaden shiga ta hanyar ninka yawan kayan da aka sayar da farashin kaya.
kuma
Canji (%)
Daidaita rahoton da aka kai a shekara ta wannan shekara tare da rahoto na shekara ta bara.
Ribar kuɗi
Ribar kuɗi shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton.
kuma
Canji (%)
Daidaita rahoton da aka kai a shekara ta wannan shekara tare da rahoto na shekara ta bara.
30/06/2021
121 155 393.60 €
-77.216 % ↓
-278 867 094.45 €
-446.331 % ↓
31/03/2021
58 136 275.95 €
+29.39 % ↑
-325 554 044.55 €
-
31/12/2020
98 964 373.20 €
-83.944 % ↓
-510 459 403.35 €
-
30/09/2020
66 394 760.40 €
+274.23 % ↑
-817 837 910.10 €
-
31/12/2019
616 375 650.45 €
-
-298 771 778.55 €
-
30/09/2019
17 741 858.25 €
-
-294 512 989.65 €
-
30/06/2019
531 766 348.95 €
-
80 520 455.55 €
-
31/03/2019
44 930 872.95 €
-
-334 485 800.25 €
-
Nuna:
To
Rahoton kudi Oncolys BioPharma Inc., tsarawa
Sabbin kwanakin Oncolys BioPharma Inc. bayanan bayanan kudi da ake samu akan layi: 31/03/2019, 31/03/2021, 30/06/2021. Kwanan wata da bayanan bayanan kuɗi an kafa su ne ta hanyar dokokin ƙasar da kamfanin yake gudanar da ayyukanta. Rahoton sabon kudi na Oncolys BioPharma Inc. yana nan akan layi akan irin wannan ranar - 30/06/2021. Babban riba Oncolys BioPharma Inc. shine ribar da kamfani ke karɓa bayan da ya rage kudin da ake samarwa da sayar da kayansa da / ko kudin da zai samar da ayyukansa. Babban riba Oncolys BioPharma Inc. ne 112 375 000 €
Dates na kudi rahotanni Oncolys BioPharma Inc.
Ribar kuɗi Oncolys BioPharma Inc. shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton. Ribar kuɗi Oncolys BioPharma Inc. ne -300 293 000 €
30/06/2021
31/03/2021
31/12/2020
30/09/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Babban riba
Babban riba shine ribar da kamfani ke karɓa bayan da ya rage kudin da ake samarwa da sayar da kayansa da / ko kudin da zai samar da ayyukansa.
104 357 043.75 €
25 236 992.40 €
95 476 363.80 €
29 575 645.20 €
566 422 638.30 €
10 055 422.20 €
523 130 832.60 €
6 359 395.20 €
Farashin farashi
Kudin shi ne yawan kuɗin da aka samar da rarraba kayayyaki da ayyuka na kamfanin.
16 798 349.85 €
32 899 283.55 €
3 488 009.40 €
36 819 115.20 €
49 953 012.15 €
7 686 436.05 €
8 635 516.35 €
38 571 477.75 €
Jimlar kudade
An kiyasta yawan kudaden shiga ta hanyar ninka yawan kayan da aka sayar da farashin kaya.
121 155 393.60 €
58 136 275.95 €
98 964 373.20 €
66 394 760.40 €
616 375 650.45 €
17 741 858.25 €
531 766 348.95 €
44 930 872.95 €
Hanyoyin shiga
Hanyoyin sarrafa kuɗi sun karu daga asusun kasuwancin kamfanin. Alal misali, mai sayar da kaya yana haifar da samun kudin shiga ta hanyar sayar da kayayyaki, kuma likita ya karbi kuɗi daga sabis na kiwon lafiya wanda ya bayar.
-
-
-
-
-
-
-
-
Haɗin aiki
Sakamakon aiki yana da ma'auni na lissafin kudi wanda ke daidaita yawan ribar da aka samu daga ayyukan kasuwanci, bayan da ya rage kudaden aiki, kamar albashi, haɓakawa da kuma kaya na kaya da aka sayar.
-275 865 697.65 €
-337 724 931.45 €
-477 979 869.60 €
-471 291 732.30 €
70 135 362.60 €
-289 522 424.55 €
82 985 092.65 €
-338 569 074.30 €
Ribar kuɗi
Ribar kuɗi shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton.
-278 867 094.45 €
-325 554 044.55 €
-510 459 403.35 €
-817 837 910.10 €
-298 771 778.55 €
-294 512 989.65 €
80 520 455.55 €
-334 485 800.25 €
R & D kudi
Binciken bincike da ci gaba - kudaden bincike don inganta samfurori da hanyoyin da ake samuwa ko kuma samar da sababbin samfurori da hanyoyin.
-
-
-
-
-
-
-
-
Ayyukan sarrafawa
Kayan aiki shine kudaden da kasuwancin ke haifarwa saboda sakamakon ayyukan kasuwanci na yau da kullum.
397 021 091.25 €
395 861 207.40 €
576 944 242.80 €
537 686 492.70 €
546 240 287.85 €
307 264 282.80 €
448 781 256.30 €
383 499 947.25 €
Abubuwan da ke yanzu
Abubuwan da ake amfani da su a yanzu shine takarda na ma'auni wanda ya wakilta dukiyar dukiyar da za'a iya juyo cikin kuɗi a cikin shekara guda.
4 637 720 817.90 €
4 865 225 209.50 €
2 364 042 017.40 €
2 493 315 669.30 €
3 553 413 290.85 €
3 125 328 857.10 €
3 425 525 184.75 €
2 318 783 331 €
Total dukiya
Jimlar dukiyar kuɗi ce ta kuɗin kuɗin kuɗin kuɗin kuɗin kungiyar, bashin bashi, da dukiya na kayan aiki.
4 826 568 295.95 €
5 073 384 892.95 €
2 596 888 932.45 €
2 751 064 334.10 €
4 067 539 004.40 €
4 001 835 159.60 €
4 342 658 996.10 €
3 074 295 825 €
Kudi na yanzu
Kasuwanci na yanzu shine kudaden kuɗin da kamfanin ya gudanar a ranar rahoton.
4 087 923 800.55 €
4 623 983 298.45 €
1 692 789 652.50 €
1 945 998 147.45 €
2 876 506 376.10 €
2 806 158 352.65 €
2 902 186 334.55 €
2 165 421 426.75 €
Yanzu bashi
Dalili na yanzu shine ɓangare na bashin da za a biya a wannan shekara (watannin 12) kuma an nuna shi a matsayin wani alhaki na yanzu da kuma ɓangare na babban kamfanonin aiki.
-
-
-
-
486 427 798.65 €
223 594 775.10 €
251 149 677.90 €
237 913 629.45 €
Jimlar kuɗi
Jimlar kuɗin kuɗi ne adadin duk kuɗin da kamfanin yake da shi a cikin asusunsa, ciki har da ƙananan kuɗi da kudade da aka gudanar a banki.
-
-
-
-
-
-
-
-
Jimlar bashi
Jimlar bashi shine haɗuwa da gajeren lokaci da dogon lokaci. Lokaci bashi ne waɗanda dole ne a biya a cikin shekara guda. Lokaci na dogon lokaci ya hada da dukan wajibai waɗanda dole ne a biya su bayan shekara guda.
-
-
-
-
859 937 329.20 €
599 851 252.35 €
648 084 404.70 €
647 759 377.20 €
Yanayin bashi
Jimlar bashi ga duk dukiya shi ne haɗin kudi wanda ya nuna yawan yawan dukiyar da kamfanin ke wakilta a matsayin bashi.
-
-
-
-
21.14 %
14.99 %
14.92 %
21.07 %
Hakki
Adalci shine adadin dukan dukiya na mai shi bayan da ya cire duk wata albashi daga dukiyar kuɗi.
4 161 138 566.55 €
4 428 582 337.35 €
1 860 387 761.25 €
2 163 652 348.50 €
3 207 601 675.20 €
3 401 983 907.25 €
3 694 574 591.40 €
2 426 536 447.80 €
Cash flow
Cash flow is bashin tsabar kuɗi da tsabar kuɗin da ake ciki a cikin kungiyar.
-
-
-
-
-
-
-
-
Rahoton kudi na baya-bayan nan game da kudin shiga na Oncolys BioPharma Inc. shine ranar 30/06/2021. A cewar sabon rahoto game da sakamakon kudi na Oncolys BioPharma Inc., yawan kudaden da Oncolys BioPharma Inc. ya samu ya kai 121 155 393.60 Yuro kuma ya canza zuwa -77.216% idan aka kwatanta da shekara ta gaba. Sakamakon riba na Oncolys BioPharma Inc. a cikin kwata na karshe shine -278 867 094.45 €, karuwar riba ta karu da -446.331% idan aka kwatanta da bara.
Kudin hannun jari Oncolys BioPharma Inc.
Kudin hannun jari Oncolys BioPharma Inc.
Sharorin Oncolys BioPharma Inc. a yau, farashin kayayyaki 2OB.F yana da layi yanzu.
